Helix Biopharma Corp.
HBP.TO
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -967.60K | -978.50K | -3.85M | -1.35M | -668.10K |
| Total Depreciation and Amortization | 1.40K | 2.90K | 2.20K | 2.90K | 2.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.20K | -149.40K | 2.53M | 11.10K | 37.00K |
| Change in Net Operating Assets | 212.50K | 494.40K | 780.00K | 505.50K | -477.70K |
| Cash from Operations | -661.50K | -630.60K | -546.30K | -829.10K | -1.11M |
| Capital Expenditure | -1.40K | -- | -1.50K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | 7.70K | 5.90K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 6.30K | 5.90K | -1.50K | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.70M | -- | 1.10M | 1.72M | 1.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.90M | -- | 800.40K | 1.27M | 700.00 |
| Foreign Exchange rate Adjustments | -- | -- | 18.30K | -5.90K | -20.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.24M | -624.70K | 270.90K | 434.80K | -1.13M |